AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Pediatric dengue vaccine is cost-effective.
2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A pediatric dengue vaccine is cost-effective in Southeast Asia.
According to published research from the United States, "To ascertain the economic feasibility of a pediatric tetravalent dengue vaccine, we developed and calibrated a cost-effectiveness model of vaccinating children at 15 months in Southeast Asia using a societal perspective. We assumed that full immunization would require two doses at prices of US$ 0.50 and US$ 10 per dose in the public and private sectors, respectively.
"The gross cost per 1,000 population (of all ages) of the vaccination program would be US$ 154," reported Donald S. Shepard and colleagues at Brandeis University. "Due to projected savings in dengue treatment, the net cost per capita would be only US$ 17 (89% below the gross cost). The cost per disability adjusted life year (DALY) saved by a pediatric vaccine would be US$ 50, making the potential vaccine highly cost-effective. Eventually, ...
- Pediatric dengue vaccine is cost-effective.
- Newspaper article from: Vaccine Weekly May 19, 2004 700+ words
...net) -- A pediatric dengue vaccine is cost-effective in Southeast Asia. According to published...a pediatric tetravalent dengue vaccine, we developed and calibrated...children at 15 months in Southeast Asia using a societal perspective...
- InViragen and Shantha Biotechnics Announce Dengue Vaccine Manufacturing...
- Press release article from: PR Newswire November 1, 2006 700+ words
...manufacture of InViragen's proprietary dengue vaccine for human clinical trials. InViragen...dengue fever every year. InViragen's dengue vaccine was designed by collaborators at the...is a major public health problem in Southeast Asia, the Pacific Islands, the Caribbean...
- SANOFI PASTEUR DENGUE VACCINE PROGRAM EXPANDED TO SINGAPORE, VIETNAM.(Clinical...
- News wire article from: AsiaPulse News April 21, 2009 700+ words
...RELEASE PR34341 Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded to Singapore...of its investigational tetravalent dengue vaccine in Singapore and Vietnam. With these...sanofi pasteur is expanding its global dengue vaccine clinical study program in Asia where...
- InViragen Receives Funding From the Pediatric Dengue Vaccine Initiative.
- Press release article from: Business Wire November 26, 2007 700+ words
...financial support from the Pediatric Dengue Vaccine Initiative (PDVI). The PDVI grant...funds for manufacture of Inviragen's dengue vaccine in preparation for testing in human...will accelerate the development of our dengue vaccine," said Dr. Dan Stinchcomb, CEO...
- Inviragen Receives Additional Grant to Support Dengue Vaccine Development.
- Newspaper article from: Vaccine Weekly September 23, 2009 700+ words
...efforts to develop a safe and effective dengue vaccine. The two-year grant will fund a...to partially support Inviragen's dengue vaccine development efforts," said Dr. Dan...preclinical characterization of our first dengue vaccine, we learned that the immune response...
- SANOFI PASTEUR AND THE PEDIATRIC DENGUE VACCINE INITIATIVE PARTNER AGAINST...
- Press release article from: PR Newswire September 29, 2006 700+ words
...sanofi-aventis, and the Pediatric Dengue Vaccine Initiative (PDVI) announced today...partnership to help develop and make a Dengue vaccine widely available for the global prevention...infected each year. At the forefront of dengue vaccine development with an active research...
- Hawaii company gets grant to develop dengue vaccine.
- News wire article from: PAC - Pacific Islands Broadcasting Association April 9, 2008 700+ words
...commercial production of the first dengue vaccine, RNZI reports. The funding will come from the Pediatric Dengue Vaccine Initiative of the Seoul-based...than 10 million in grants for the dengue vaccine programme over the past five years...
- HAWAII BIOTECH BEGINS PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE.
- Newspaper article from: Biotech Business October 1, 2009 700+ words
...clinical study with their monovalent dengue vaccine candidate. The double-blind, placebo...testing of Hawaii Biotech's tetravalent dengue vaccine." Hawaii Biotech's dengue monovalent...to enter clinical studies. Previous dengue vaccine candidates tested in the clinic have...
